Document Detail


Antipsychotics During Pregnancy: Relation to Fetal and Maternal Metabolic EffectsAntipsychotics During Pregnancy.
MedLine Citation:
PMID:  22752236     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
CONTEXT Knowledge about the effects of exposure to the newer antipsychotics during pregnancy is limited. OBJECTIVE To investigate the effects of maternal use of antipsychotics during pregnancy on gestational diabetes and fetal growth. DESIGN Population-based cohort study comparing women exposed and not exposed to antipsychotics during pregnancy. Exposure was defined as prescriptions filled. SETTING Swedish national health registers. PARTICIPANTS All women giving birth in Sweden from July 1, 2005, through December 31, 2009, grouped by filled prescriptions for (1) olanzapine and/or clozapine, the most obesogenic and diabetogenic antipsychotics (n = 169), (2) other antipsychotics (n = 338), or (3) no antipsychotics (n = 357 696). MAIN OUTCOME MEASURES Odds ratios (ORs) with 95% CIs for gestational diabetes and being small for gestational age (SGA) and large for gestational age for birth weight, birth length, and head circumference. RESULTS Exposure to other antipsychotics was associated with an increased risk of gestational diabetes (adjusted OR, 1.77 [95% CI, 1.04-3.03]). The risk increase with olanzapine and/or clozapine was of similar magnitude but not statistical significance (adjusted OR, 1.94 [95% CI, 0.97-3.91]). Infants exposed to either group of antipsychotics had increased risks of being SGA on birth weight, whereas only exposure to other antipsychotics yielded increased risks of being SGA for birth length and head circumference. None of the risks for SGA measurements remained significant after adjusting for maternal factors. There were no increased risks of being large for gestational age for birth weight or birth length after exposure to olanzapine and/or clozapine, but the risk increased for head circumference (OR, 3.02 [95% CI, 1.60-5.71]). CONCLUSIONS Women who used antipsychotics during pregnancy had increased risks of gestational diabetes. The increased risks of giving birth to an SGA infant seemed to be an effect of confounders, such as smoking. Except for macrocephaly, olanzapine and/or clozapine exposure was not associated with anabolic fetal growth.
Authors:
Robert Bodén; Maria Lundgren; Lena Brandt; Johan Reutfors; Helle Kieler
Related Documents :
10725986 - Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for ...
7589756 - Successful management of congenital protein c deficiency with recurrent pregnancy loss.
21728916 - Gestational diabetes mellitus complicating twin pregnancies.
11093406 - Outcome of pregnancy in women with mechanical valves.
15577206 - Membrane localization of transporter associated with antigen processing (tap)-like (abc...
16908066 - The importance of alcohol misuse, malnutrition and genetic susceptibility on brain grow...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of general psychiatry     Volume:  69     ISSN:  1538-3636     ISO Abbreviation:  Arch. Gen. Psychiatry     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372435     Medline TA:  Arch Gen Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  715-21     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A latent class analysis of dissociation and posttraumatic stress disorder: evidence for a dissociati...
Next Document:  Genome-wide Epigenetic Regulation by Early-Life TraumaGenome Epigenetic Regulation by Early-Life Tra...